Ureaplasma serovars & their antimicrobial susceptibility in patients of infertility & genital tract infections

Indian Journal of Medical Research

Volumn 136, Issue 6, 2012, Pages 991-996

  Dhawan, Benu ^a   Malhotra, Neena ^a   Srinivas, Vishnubhatla ^a   Rawre, Jyoti ^a   Khanna, Neena ^a   Chaudhry, Rama ^a   Mittal, Suneeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antimicrobial susceptibility; Pcr; Ureaplasma serovars

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; JOSAMYCIN; OFLOXACIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; CANDIDIASIS; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOPLASMA HOMINIS; POLYMERASE CHAIN REACTION; SEROTYPING; UREAPLASMA INFECTION; UREAPLASMA PARVUM; ADULT; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; SPECIES DIFFERENCE; UREAPLASMA; UREAPLASMA INFECTIONS;

ADULT; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; DOXYCYCLINE; FEMALE; HUMANS; INFERTILITY; JOSAMYCIN; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; POLYMERASE CHAIN REACTION; REPRODUCTIVE TRACT INFECTIONS; SEROTYPING; SPECIES SPECIFICITY; UREAPLASMA; UREAPLASMA INFECTIONS;

EID: 84873133661     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bayraktar RM, Ozerol HI, Gucluer N, Celik O. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis 2010; 14: 90-5.
2. Waites KB, Katz B, Schelonka RL. Mycoplasmas and Ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18: 757-89.
3. Gupta A, Gupta A, Gupta S, Mttal A, Chandra P, Gill AK. Correlation of mycoplasma with unexplained infertility. Arch Gynecol Obstet 2009; 280: 981-5.
4. Jais M, Joshi SG. Correlation of Ureaplasma urealyticum with infertility. Indian J Sex Transm Dis 1998; 19: 45-7.
5. Dhawan B, Gupta V, Khanna N, Singh M, Chaudhry R. Evaluation of the Diagnostic Effcacy of PCR for Ureaplasma urealyticum infection in Indian adults with symptoms of genital discharge. Jpn J Infect Dis 2006; 59: 57-8.
6. Bhandari H, Malhotra S, Sharma M, Kumar B. Mcrofora of women with chronic cervicitis. J Indian Med Assoc 2000; 98: 384-6.
7. Francesco De MA, Negrini R, Pinsi G, Peroni L. Detection of Ureaplasma biovar and polymerase chain reaction based-subtyping of Ureaplasma parvum in women with or without symptoms of genital infections. Eur J Microbiol Infect Dis 2009; 28: 641-6.
8. Gupta V, Dhawan B, Khanna N, Agarwal N, Bhattacharya SN, Sreenivas V, et al. Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infections. Diag Microbiol Infect Dis 2008; 60: 95-7.
9. Abele-Horn M, Wollf C, Dressel P, Pfaff F, Zimmermann A. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetrics patients and gynaecological patients with pelvic infammatory disease. J Clin Microbiol 1997; 35: 1199-1202.
10. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M. pneumonia and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifoxacin, linezolid, moxifoxacin, quinupristin-dalfopristin and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines and quinolones. Antimicrob Agents Chemother 2001; 45: 2604-8.
11. Stellrecht KA, Woron MA, Mishrik GN, Venezia AR. Comparison of multiplex PCR assay with culture for detection of genital mycoplasmas. J Clin Microbiol 2004; 42: 1528-33.
12. Knox CL, Timms P. Comparison of PCR, nested PCR and random amplifed polymorphic DNA PCR for detection and typing of Ureaplasma urealyticum in specimens from pregnant women. J Clin Microbiol 1998; 36: 3032-9.
13. nd ed. Washington, D.C. ASM Press; 2004. p. 3.15.1-17.
14. Krausse R, Schubert S. In vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma spp. isolated in Germany over 20 years. Clin Microbiol Infect 2010; 16: 1649-55.
15. Centres for Disease Control and Prevention: Disease characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines. Morb Mortal Wkly Rep 2002; 51: 30-42.
16. Robertz MC, Kenny GE. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob Agents Chemother 1986; 29: 350-2.
17. Ullmann U, Schubert S, Krausse R. Comparative in vitro activity of levofoxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. J Antimicrob Chemother 1999; 43 (Suppl C): 33-6.
18. Lin HP, Lu HX. Analysis of detection and antimicrobial resistance of pathogens in prostatic secretion from 1186 infertile men with chronic prostatitis. Zhonghua Nan Ke Xue 2007;75: 628-31.
19. Kilic D, Basar MM, Kaygusuz S, Yilmaz E, Basar H, Baiislam E. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in patients with non-gonococcal urethritis. Jpn J Infect Dis 2004; 57: 17-20.
20. Duffy LB, Crabb D, Searcey K, Kempf MC. Comparative potency of gemifoxacin, new quinolones, tetracycline and clindamycin against Mycoplasma spp. J Antimicrob Chemother 2000; 45 (Suppl S1): 29-33.